Serveur d'exploration sur la grippe en Espagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Th17 serum cytokines in relation to laboratory-confirmed respiratory viral infection: A pilot study.

Identifieur interne : 000017 ( Main/Exploration ); précédent : 000016; suivant : 000018

Th17 serum cytokines in relation to laboratory-confirmed respiratory viral infection: A pilot study.

Auteurs : Emmanouil Antalis [Grèce] ; Aris Spathis [Grèce] ; Christine Kottaridi [Grèce] ; Athanasios Kossyvakis [Grèce] ; Kalliopi Pastellas [Grèce] ; Konstantinos Tsakalos [Grèce] ; Andreas Mentis [Grèce] ; Christos Kroupis [Grèce] ; Sotirios Tsiodras [Grèce]

Source :

RBID : pubmed:30715745

Descripteurs français

English descriptors

Abstract

BACKGROUND

Th17 cytokines are associated with modulation of inflammation and may be beneficial in clearing influenza infection in experimental models. The Th17 cytokine profile was evaluated in a pilot study of respiratory virus infections.

METHODS

Consecutive patients with symptoms of respiratory tract infection visiting the emergency department of a tertiary care hospital during the winter influenza season of 2014 to 2015 were evaluated. CLART PneumoVir kit, (GENOMICA, Madrid, Spain) was used for viral detection of all known respiratory viruses. Th17 cytokine profile was evaluated with the MILLIPLEX MAP Human TH17 Magnetic Bead Panel (Millipore Corp., Billerica, MA). Correlation of the TH17 profile with viral detection was performed with univariate and multivariate analysis.

RESULTS

Seventy-six patients were evaluated (median age 56 years, 51.3% female); a respiratory virus was identified in 60 (78.9%) patients; 45% had confirmed influenza. Influenza A (H3N2) correlated with higher levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 1β (IL-1β), IL-17A, IL-17E, IL-17F, IL-21, IL-22, and IL-23 (P < 0.05 by analysis of variance [ANOVA]) compared with respiratory syncytial virus (RSV). Parainfluenza virus (PIV) similarly had higher levels of GM-CSF, IL-1b, IL-17A, IL-22 compared with those detected in RSV, influenza B and any other virus infection ( P < 0.05; ANOVA). Increasing age (β-coefficient = 1.11, 95% CI, 1.04-1.2, P < 0.01) as well as IL-17A levels (β-coefficient = 1.03, 95% CI, 1.001-1.05, P = 0.04) predicted hospital admission.

CONCLUSION

Main Th17 cell effector cytokines were upregulated in laboratory-confirmed A(H3N2) influenza and PIV. Excessive amounts of Th17 cytokines may be implicated in the pathogenesis and immune control of acute influenza and PIV infection in humans and may predict the severity of disease.


DOI: 10.1002/jmv.25406
PubMed: 30715745
PubMed Central: PMC7166444


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Th17 serum cytokines in relation to laboratory-confirmed respiratory viral infection: A pilot study.</title>
<author>
<name sortKey="Antalis, Emmanouil" sort="Antalis, Emmanouil" uniqKey="Antalis E" first="Emmanouil" last="Antalis">Emmanouil Antalis</name>
<affiliation wicri:level="3">
<nlm:affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>4th Department of Internal Medicine, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Spathis, Aris" sort="Spathis, Aris" uniqKey="Spathis A" first="Aris" last="Spathis">Aris Spathis</name>
<affiliation wicri:level="3">
<nlm:affiliation>2nd Department of Pathology, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>2nd Department of Pathology, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kottaridi, Christine" sort="Kottaridi, Christine" uniqKey="Kottaridi C" first="Christine" last="Kottaridi">Christine Kottaridi</name>
<affiliation wicri:level="3">
<nlm:affiliation>2nd Department of Pathology, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>2nd Department of Pathology, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kossyvakis, Athanasios" sort="Kossyvakis, Athanasios" uniqKey="Kossyvakis A" first="Athanasios" last="Kossyvakis">Athanasios Kossyvakis</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pastellas, Kalliopi" sort="Pastellas, Kalliopi" uniqKey="Pastellas K" first="Kalliopi" last="Pastellas">Kalliopi Pastellas</name>
<affiliation wicri:level="3">
<nlm:affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>4th Department of Internal Medicine, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tsakalos, Konstantinos" sort="Tsakalos, Konstantinos" uniqKey="Tsakalos K" first="Konstantinos" last="Tsakalos">Konstantinos Tsakalos</name>
<affiliation wicri:level="3">
<nlm:affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>4th Department of Internal Medicine, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mentis, Andreas" sort="Mentis, Andreas" uniqKey="Mentis A" first="Andreas" last="Mentis">Andreas Mentis</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kroupis, Christos" sort="Kroupis, Christos" uniqKey="Kroupis C" first="Christos" last="Kroupis">Christos Kroupis</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Biochemistry, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Clinical Biochemistry, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tsiodras, Sotirios" sort="Tsiodras, Sotirios" uniqKey="Tsiodras S" first="Sotirios" last="Tsiodras">Sotirios Tsiodras</name>
<affiliation wicri:level="3">
<nlm:affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>4th Department of Internal Medicine, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30715745</idno>
<idno type="pmid">30715745</idno>
<idno type="doi">10.1002/jmv.25406</idno>
<idno type="pmc">PMC7166444</idno>
<idno type="wicri:Area/Main/Corpus">00026</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00026</idno>
<idno type="wicri:Area/Main/Curation">000026</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000026</idno>
<idno type="wicri:Area/Main/Exploration">000026</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Th17 serum cytokines in relation to laboratory-confirmed respiratory viral infection: A pilot study.</title>
<author>
<name sortKey="Antalis, Emmanouil" sort="Antalis, Emmanouil" uniqKey="Antalis E" first="Emmanouil" last="Antalis">Emmanouil Antalis</name>
<affiliation wicri:level="3">
<nlm:affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>4th Department of Internal Medicine, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Spathis, Aris" sort="Spathis, Aris" uniqKey="Spathis A" first="Aris" last="Spathis">Aris Spathis</name>
<affiliation wicri:level="3">
<nlm:affiliation>2nd Department of Pathology, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>2nd Department of Pathology, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kottaridi, Christine" sort="Kottaridi, Christine" uniqKey="Kottaridi C" first="Christine" last="Kottaridi">Christine Kottaridi</name>
<affiliation wicri:level="3">
<nlm:affiliation>2nd Department of Pathology, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>2nd Department of Pathology, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kossyvakis, Athanasios" sort="Kossyvakis, Athanasios" uniqKey="Kossyvakis A" first="Athanasios" last="Kossyvakis">Athanasios Kossyvakis</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pastellas, Kalliopi" sort="Pastellas, Kalliopi" uniqKey="Pastellas K" first="Kalliopi" last="Pastellas">Kalliopi Pastellas</name>
<affiliation wicri:level="3">
<nlm:affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>4th Department of Internal Medicine, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tsakalos, Konstantinos" sort="Tsakalos, Konstantinos" uniqKey="Tsakalos K" first="Konstantinos" last="Tsakalos">Konstantinos Tsakalos</name>
<affiliation wicri:level="3">
<nlm:affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>4th Department of Internal Medicine, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mentis, Andreas" sort="Mentis, Andreas" uniqKey="Mentis A" first="Andreas" last="Mentis">Andreas Mentis</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kroupis, Christos" sort="Kroupis, Christos" uniqKey="Kroupis C" first="Christos" last="Kroupis">Christos Kroupis</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Biochemistry, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Clinical Biochemistry, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tsiodras, Sotirios" sort="Tsiodras, Sotirios" uniqKey="Tsiodras S" first="Sotirios" last="Tsiodras">Sotirios Tsiodras</name>
<affiliation wicri:level="3">
<nlm:affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>4th Department of Internal Medicine, University of Athens Medical School, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of medical virology</title>
<idno type="eISSN">1096-9071</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Cytokines (blood)</term>
<term>Cytokines (immunology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Interleukin-17 (blood)</term>
<term>Interleukin-23 (blood)</term>
<term>Interleukins (blood)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pilot Projects (MeSH)</term>
<term>Respiratory Tract Infections (diagnosis)</term>
<term>Respiratory Tract Infections (immunology)</term>
<term>Respiratory Tract Infections (virology)</term>
<term>Spain (MeSH)</term>
<term>Th17 Cells (immunology)</term>
<term>Virus Diseases (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Cellules Th17 (immunologie)</term>
<term>Cytokines (immunologie)</term>
<term>Cytokines (sang)</term>
<term>Espagne (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections de l'appareil respiratoire (diagnostic)</term>
<term>Infections de l'appareil respiratoire (immunologie)</term>
<term>Infections de l'appareil respiratoire (virologie)</term>
<term>Interleukine-17 (sang)</term>
<term>Interleukine-23 (sang)</term>
<term>Interleukines (sang)</term>
<term>Maladies virales (immunologie)</term>
<term>Mâle (MeSH)</term>
<term>Projets pilotes (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Cytokines</term>
<term>Interleukin-17</term>
<term>Interleukin-23</term>
<term>Interleukins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Cytokines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Cellules Th17</term>
<term>Cytokines</term>
<term>Infections de l'appareil respiratoire</term>
<term>Maladies virales</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Respiratory Tract Infections</term>
<term>Th17 Cells</term>
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Cytokines</term>
<term>Interleukine-17</term>
<term>Interleukine-23</term>
<term>Interleukines</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pilot Projects</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Espagne</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Projets pilotes</term>
<term>Sujet âgé</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Th17 cytokines are associated with modulation of inflammation and may be beneficial in clearing influenza infection in experimental models. The Th17 cytokine profile was evaluated in a pilot study of respiratory virus infections.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Consecutive patients with symptoms of respiratory tract infection visiting the emergency department of a tertiary care hospital during the winter influenza season of 2014 to 2015 were evaluated. CLART PneumoVir kit, (GENOMICA, Madrid, Spain) was used for viral detection of all known respiratory viruses. Th17 cytokine profile was evaluated with the MILLIPLEX MAP Human TH17 Magnetic Bead Panel (Millipore Corp., Billerica, MA). Correlation of the TH17 profile with viral detection was performed with univariate and multivariate analysis.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Seventy-six patients were evaluated (median age 56 years, 51.3% female); a respiratory virus was identified in 60 (78.9%) patients; 45% had confirmed influenza. Influenza A (H3N2) correlated with higher levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 1β (IL-1β), IL-17A, IL-17E, IL-17F, IL-21, IL-22, and IL-23 (P < 0.05 by analysis of variance [ANOVA]) compared with respiratory syncytial virus (RSV). Parainfluenza virus (PIV) similarly had higher levels of GM-CSF, IL-1b, IL-17A, IL-22 compared with those detected in RSV, influenza B and any other virus infection ( P < 0.05; ANOVA). Increasing age (β-coefficient = 1.11, 95% CI, 1.04-1.2, P < 0.01) as well as IL-17A levels (β-coefficient = 1.03, 95% CI, 1.001-1.05, P = 0.04) predicted hospital admission.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>Main Th17 cell effector cytokines were upregulated in laboratory-confirmed A(H3N2) influenza and PIV. Excessive amounts of Th17 cytokines may be implicated in the pathogenesis and immune control of acute influenza and PIV infection in humans and may predict the severity of disease.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">30715745</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>03</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1096-9071</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>91</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2019</Year>
<Month>06</Month>
</PubDate>
</JournalIssue>
<Title>Journal of medical virology</Title>
<ISOAbbreviation>J. Med. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Th17 serum cytokines in relation to laboratory-confirmed respiratory viral infection: A pilot study.</ArticleTitle>
<Pagination>
<MedlinePgn>963-971</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.25406</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND">Th17 cytokines are associated with modulation of inflammation and may be beneficial in clearing influenza infection in experimental models. The Th17 cytokine profile was evaluated in a pilot study of respiratory virus infections.</AbstractText>
<AbstractText Label="METHODS">Consecutive patients with symptoms of respiratory tract infection visiting the emergency department of a tertiary care hospital during the winter influenza season of 2014 to 2015 were evaluated. CLART PneumoVir kit, (GENOMICA, Madrid, Spain) was used for viral detection of all known respiratory viruses. Th17 cytokine profile was evaluated with the MILLIPLEX MAP Human TH17 Magnetic Bead Panel (Millipore Corp., Billerica, MA). Correlation of the TH17 profile with viral detection was performed with univariate and multivariate analysis.</AbstractText>
<AbstractText Label="RESULTS">Seventy-six patients were evaluated (median age 56 years, 51.3% female); a respiratory virus was identified in 60 (78.9%) patients; 45% had confirmed influenza. Influenza A (H3N2) correlated with higher levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 1β (IL-1β), IL-17A, IL-17E, IL-17F, IL-21, IL-22, and IL-23 (P < 0.05 by analysis of variance [ANOVA]) compared with respiratory syncytial virus (RSV). Parainfluenza virus (PIV) similarly had higher levels of GM-CSF, IL-1b, IL-17A, IL-22 compared with those detected in RSV, influenza B and any other virus infection ( P < 0.05; ANOVA). Increasing age (β-coefficient = 1.11, 95% CI, 1.04-1.2, P < 0.01) as well as IL-17A levels (β-coefficient = 1.03, 95% CI, 1.001-1.05, P = 0.04) predicted hospital admission.</AbstractText>
<AbstractText Label="CONCLUSION">Main Th17 cell effector cytokines were upregulated in laboratory-confirmed A(H3N2) influenza and PIV. Excessive amounts of Th17 cytokines may be implicated in the pathogenesis and immune control of acute influenza and PIV infection in humans and may predict the severity of disease.</AbstractText>
<CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Antalis</LastName>
<ForeName>Emmanouil</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spathis</LastName>
<ForeName>Aris</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>2nd Department of Pathology, University of Athens Medical School, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kottaridi</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>2nd Department of Pathology, University of Athens Medical School, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kossyvakis</LastName>
<ForeName>Athanasios</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pastellas</LastName>
<ForeName>Kalliopi</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsakalos</LastName>
<ForeName>Konstantinos</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mentis</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>National Influenza Reference Laboratory for Southern Greece, Hellenic Pasteur Institute, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kroupis</LastName>
<ForeName>Christos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Biochemistry, University of Athens Medical School, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsiodras</LastName>
<ForeName>Sotirios</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-0463-4321</Identifier>
<AffiliationInfo>
<Affiliation>4th Department of Internal Medicine, University of Athens Medical School, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>02</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Med Virol</MedlineTA>
<NlmUniqueID>7705876</NlmUniqueID>
<ISSNLinking>0146-6615</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053759">Interleukin-23</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007378">Interleukins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>MKM3CA6LT1</RegistryNumber>
<NameOfSubstance UI="C416243">interleukin-21</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>XEO71E2E45</RegistryNumber>
<NameOfSubstance UI="C415368">interleukin-22</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020381" MajorTopicYN="N">Interleukin-17</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053759" MajorTopicYN="N">Interleukin-23</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058504" MajorTopicYN="N">Th17 Cells</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">IL-17</Keyword>
<Keyword MajorTopicYN="Y">RSV</Keyword>
<Keyword MajorTopicYN="Y">Th17</Keyword>
<Keyword MajorTopicYN="Y">influenza</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>07</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>12</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>01</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>3</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30715745</ArticleId>
<ArticleId IdType="doi">10.1002/jmv.25406</ArticleId>
<ArticleId IdType="pmc">PMC7166444</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2009 Aug 27;361(9):888-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19710487</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2007 Aug 6;204(8):1837-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17635955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2015 Jan 29;20(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25655052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2011 Feb 1;186(3):1666-1674</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21178015</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Immunol. 2017 May;38(5):310-322</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28254169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Leukoc Biol. 2014 May;95(5):809-815</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24407884</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Immunol. 2007 Dec;19(6):377-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18054248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Immunol. 2010 Dec;137(3):303-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20943443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Respir Res. 2017 Aug 3;18(1):147</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28774302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 Mar 15;182(6):3469-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19265125</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Pulmonol. 2011 Dec;46(12):1233-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21626718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2014 May;184(5):1274-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24650560</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Res. 2016 Nov;80(5):702-709</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27486703</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Public Health. 2013 Mar;103(3):e43-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23327249</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2018 Jun;58(6):717-726</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29314865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2008 Jun 20;376(1):53-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18420248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 Oct 15;183(8):5301-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19783685</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(10):e26050</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22022504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2014 Nov 17;211(12):2397-410</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25366965</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genet Mol Res. 2016 Mar 24;15(1):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27050987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care. 2009;13(6):R201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20003352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2010 Jan 20;396(2):178-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19913271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Clin Exp Med. 2014 Dec 15;7(12):5593-602</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25664078</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2006 May;7(5):517-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16565719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 1998 Feb 1;101(3):643-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9449698</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mod Pathol. 2013 Mar;26(3):357-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23174938</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010 Oct 01;5(10):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20957032</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22390970</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2011 Jul;179(1):248-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21703407</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Mar 15;50(6):850-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20136415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2017 Dec;148:20-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29100887</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2019 Jun;91(6):963-971</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30715745</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2012 Mar 09;12(4):295-305</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22402670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 1999 Oct 6;282(13):1240-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10517426</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 2008 Apr;28(4):454-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18400188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2014 May;14(5):315-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24762827</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2012 Mar;22(3):528-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22025253</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Grèce</li>
</country>
<region>
<li>Attique (région)</li>
</region>
<settlement>
<li>Athènes</li>
</settlement>
</list>
<tree>
<country name="Grèce">
<region name="Attique (région)">
<name sortKey="Antalis, Emmanouil" sort="Antalis, Emmanouil" uniqKey="Antalis E" first="Emmanouil" last="Antalis">Emmanouil Antalis</name>
</region>
<name sortKey="Kossyvakis, Athanasios" sort="Kossyvakis, Athanasios" uniqKey="Kossyvakis A" first="Athanasios" last="Kossyvakis">Athanasios Kossyvakis</name>
<name sortKey="Kottaridi, Christine" sort="Kottaridi, Christine" uniqKey="Kottaridi C" first="Christine" last="Kottaridi">Christine Kottaridi</name>
<name sortKey="Kroupis, Christos" sort="Kroupis, Christos" uniqKey="Kroupis C" first="Christos" last="Kroupis">Christos Kroupis</name>
<name sortKey="Mentis, Andreas" sort="Mentis, Andreas" uniqKey="Mentis A" first="Andreas" last="Mentis">Andreas Mentis</name>
<name sortKey="Pastellas, Kalliopi" sort="Pastellas, Kalliopi" uniqKey="Pastellas K" first="Kalliopi" last="Pastellas">Kalliopi Pastellas</name>
<name sortKey="Spathis, Aris" sort="Spathis, Aris" uniqKey="Spathis A" first="Aris" last="Spathis">Aris Spathis</name>
<name sortKey="Tsakalos, Konstantinos" sort="Tsakalos, Konstantinos" uniqKey="Tsakalos K" first="Konstantinos" last="Tsakalos">Konstantinos Tsakalos</name>
<name sortKey="Tsiodras, Sotirios" sort="Tsiodras, Sotirios" uniqKey="Tsiodras S" first="Sotirios" last="Tsiodras">Sotirios Tsiodras</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000017 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000017 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30715745
   |texte=   Th17 serum cytokines in relation to laboratory-confirmed respiratory viral infection: A pilot study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30715745" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021